Catalyst Pharmaceuticals Inc

CPRX

Healthcare|Biotechnology|USA

$31.48

+0.00 (+0.00%)

DCF (FCF)

$21.18

Tangible Book

$7.29

Graham Number

$18.16

Earnings Power

$15.91

Upcoming Data Readouts (4)

Nov 2026

Est. completion

NADSD

Breaking Silence Through Story: A Narrative Medicine Intervention for Parents of Children With Urogenital Conditions

Feb 2028

Est. completion

P1PROC

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Dec 2028

Est. completion

Bladder Cancer

Blue Light Cystoscopy With Cysview® Registry

Feb 2032

Est. completion

Duchenne Muscular Dystrophy

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

Trials past primary completion date but still active — data readout may be imminent.

May 2026

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD